Orbis Medicines and the DCAI have enhanced their oral macrocycle drug discovery platform using advanced AI capabilities of the Gefion Supercomputer. This includes algorithms for optimizing molecular structures and assessing drug interactions, with implications for rapid drug development in global pharmaceutical endeavors.